NCT06812403

Combination COMBO Endoscopy Oropharyngeal Airway With High-Flow Nasal Cannula Oxygenation in Sedated Gastrointestinal Endoscopy for Obese Patients

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 50 (actual)
• Sponsor: Zhejiang University · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

Hypoxia is the most common adverse event during propofol sedation for gastrointestinal endoscopy, particularly in obese patients. A recent innovation in this domain is the COMBO Endoscopy Oropharyngeal Airway-a multifaceted device that encompasses capnography monitoring, bite block , oxygenation support, and oropharyngeal airway management. This device has been purposefully designed to cater to the unique requirements of endoscopic procedures. The principal objective of this study is to evaluate the efficacy of the COMBO Endoscopy Oropharyngeal Airway in combination with High-Flow Nasal Cannula Oxygenation for reducing the incidence of hypoxia in obese patients undergoing gastrointestinal endoscopy under sedation.

Conditions

• Hypoxia
• Esophageal Cancer
• Gastric Cancer
• Polyp of Colon

Interventions

Type	Name	Description
DEVICE	the COMBO Endoscopy Oropharyngeal Airway with High-Flow Nasal Cannula Oxygenation	Using the COMBO Endoscopy Oropharyngeal Airway with High-Flow Nasal Cannula Oxygenation in Sedated Gastrointestinal Endoscopy for Obese Patients

Timeline

• Start date: 2025-02-04
• Primary completion: 2025-06-04
• Completion: 2025-06-04
• First posted: 2025-02-06
• Last updated: 2025-06-25

Locations

1 site across 1 country: China